Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,233 | -5,505 | -45,540 | -18,648 | -12,640 |
| Depreciation Amortization | 634 | 332 | 1,686 | 1,308 | 881 |
| Income taxes - deferred | N/A | N/A | 5 | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | 83 | N/A |
| Accounts payable and accrued liabilities | -432 | -678 | -688 | -1,180 | -795 |
| Other Working Capital | -4,773 | -5,100 | 3,640 | -925 | -1,021 |
| Other Operating Activity | 3,320 | 1,982 | 977 | 2,394 | 866 |
| Operating Cash Flow | $-13,484 | $-8,969 | $-39,920 | $-16,968 | $-12,709 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -289 | -255 | -145 |
| Other Investing Activity | 5 | 9 | 0 | 0 | 0 |
| Investing Cash Flow | $5 | $9 | $-289 | $-255 | $-145 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -10,250 | -10,000 | -10,000 |
| Debt Repayment | N/A | N/A | N/A | -250 | -250 |
| Financing Cash Flow | $N/A | $N/A | $-10,250 | $-10,250 | $-10,250 |
| Exchange Rate Effect | -2,544 | -1,132 | 3,333 | 2,163 | 3,365 |
| Beginning Cash Position | 125,551 | 125,551 | 172,677 | 172,677 | 172,677 |
| End Cash Position | 109,528 | 115,459 | 125,551 | 147,367 | 152,938 |
| Net Cash Flow | $-16,023 | $-10,092 | $-47,126 | $-25,310 | $-19,739 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,484 | -8,969 | -39,920 | -16,968 | -12,709 |
| Capital Expenditure | N/A | N/A | -289 | -255 | -145 |
| Free Cash Flow | -13,484 | -8,969 | -40,209 | -17,223 | -12,854 |